Cargando…

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

SARS-CoV-2 protein subunit vaccines are currently being evaluated by multiple manufacturers to address the global vaccine equity gap, and need for low-cost, easy to scale, safe, and effective COVID-19 vaccines. In this paper, we report on the generation of the receptor-binding domain RBD203-N1 yeast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wen-Hsiang, Pollet, Jeroen, Strych, Ulrich, Lee, Jungsoon, Liu, Zhuyun, Kundu, Rakhi Tyagi, Versteeg, Leroy, Villar, Maria Jose, Adhikari, Rakesh, Wei, Junfei, Poveda, Cristina, Keegan, Brian, Bailey, Aaron Oakley, Chen, Yi-Lin, Gillespie, Portia M., Kimata, Jason T., Zhan, Bin, Hotez, Peter J., Bottazzi, Maria Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529586/ https://www.ncbi.nlm.nih.gov/pubmed/34688919 http://dx.doi.org/10.1016/j.pep.2021.106003

Ejemplares similares

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
por: Pollet, Jeroen, et al.
Publicado: (2021)

Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1
por: Lee, Jungsoon, et al.
Publicado: (2021)

A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
por: Thimmiraju, Syamala Rani, et al.
Publicado: (2023)

Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2021)

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
por: Pollet, Jeroen, et al.
Publicado: (2022)

Protective immunity elicited by the nematode-conserved As37 recombinant protein against Ascaris suum infection
por: Versteeg, Leroy, et al.
Publicado: (2020)

Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8(+) T-cells
por: Poveda, Cristina, et al.
Publicado: (2023)

Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune response
por: Wei, Junfei, et al.
Publicado: (2017)

Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi
por: Versteeg, Leroy, et al.
Publicado: (2021)

Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine Candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates
por: Wei, Junfei, et al.
Publicado: (2016)

Identification, Characterization, and Structure of Tm16 from Trichuris muris
por: Liu, Zhuyun, et al.
Publicado: (2017)

Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2017)

Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
por: Cruz-Chan, Julio V., et al.
Publicado: (2021)

Trichuris muris whey acidic protein induces type 2 protective immunity against whipworm
por: Briggs, Neima, et al.
Publicado: (2018)

2257: Vaccine efficacy and immunogenicity of recombinant WAP and CAP-1 proteins in AKR mice
por: Briggs, Neima, et al.
Publicado: (2018)

A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection
por: Barry, Meagan A., et al.
Publicado: (2019)

Coronavirus vaccine-associated lung immunopathology-what is the significance?
por: Bottazzi, Maria Elena, et al.
Publicado: (2020)

COVID-19 vaccines: neutralizing antibodies and the alum advantage
por: Hotez, Peter J., et al.
Publicado: (2020)

The SARS-CoV-2 Vaccine Pipeline: an Overview
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease
por: Jones, Kathryn M., et al.
Publicado: (2023)

Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
por: Versteeg, Leroy, et al.
Publicado: (2019)

Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice
por: Wei, Junfei, et al.
Publicado: (2022)

Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens
por: Poveda, Cristina, et al.
Publicado: (2019)

A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates
por: Pino, Maria, et al.
Publicado: (2021)

Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection
por: Arumugam, Sridhar, et al.
Publicado: (2016)

The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection
por: Nguyen, Duc Minh, et al.
Publicado: (2023)

The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection
por: Nguyen, Duc Minh, et al.
Publicado: (2023)

Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine
por: Seid, Christopher A, et al.
Publicado: (2015)

Signal Transducer and Activator of Transcription-3 Modulation of Cardiac Pathology in Chronic Chagasic Cardiomyopathy
por: Hoffman, Kristyn A., et al.
Publicado: (2021)

Neglected Tropical Diseases among the Association of Southeast Asian Nations (ASEAN): Overview and Update
por: Hotez, Peter J., et al.
Publicado: (2015)

Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
por: Nyon, Mun Peak, et al.
Publicado: (2018)

Recombinant protein vaccines, a proven approach against coronavirus pandemics
por: Pollet, Jeroen, et al.
Publicado: (2021)

Developing a low-cost and accessible COVID-19 vaccine for global health
por: Hotez, Peter J., et al.
Publicado: (2020)

“Running the Gauntlet”: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a “Call to Action”
por: Bottazzi, Maria Elena, et al.
Publicado: (2019)

Human Schistosomiasis Vaccines as Next Generation Control Tools
por: Hotez, Peter J., et al.
Publicado: (2023)

Global COVID-19 Efforts as the Platform to Achieving the Sustainable Development Goals
por: Mejia, Rojelio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n9f7r65bgu1emn318vu9c6nucs